TY - JOUR
T1 - Changes of vitamin D levels and bone turnover markers after CPAP therapy
T2 - a randomized sham-controlled trial
AU - Theorell-Haglöw, Jenny
AU - Hoyos, Camilla M.
AU - Phillips, Craig L.
AU - Yee, Brendon J.
AU - Herrmann, Markus
AU - Brennan-Speranza, Tara C.
AU - Grunstein, Ronald R.
AU - Liu, Peter Y.
PY - 2018/8
Y1 - 2018/8
N2 - The aim was to investigate whether continuous positive airway pressure treatment could modulate serum vitamin D (25-hydroxyvitamin D) and bone turnover markers (collagen-type 1 cross-linked C-telopeptide, osteocalcin and N-terminal propeptide of type 1 collagen) in secondary analysis from a randomized controlled trial. Sixty-five continuous positive airway pressure-naïve male patients with obstructive sleep apnea (age = 49 ± 12 years, apnea–hypopnea index = 39.9 ± 17.7 events h−1, body mass index = 31.3 ± 5.2 kg m−2) were randomized to receive either real (n = 34) or sham (n = 31) continuous positive airway pressure for 12 weeks. At 12 weeks, all participants received real continuous positive airway pressure for an additional 12 weeks. After 12 weeks of continuous positive airway pressure (real versus sham), there were no between-group differences for any of the main outcomes [Δ25-hydroxyvitamin D: −0.80 ± 5.28 ng mL−1 (mean ± SE) versus 3.08 ± 3.66 ng mL−1, P = 0.42; Δcollagen-type 1 cross-linked C-telopeptide: 0.011 ± 0.014 ng mL−1 versus −0.004 ± 0.009 ng mL−1, P = 0.48; Δosteocalcin: 1.13 ± 1.12 ng mL−1 versus 0.46 ± 0.75 ng mL−1, P = 0.80; ΔN-terminal propeptide of type 1 collagen: 2.07 ± 3.05 μg L−1 versus −1.05 ± 2.13 μg L−1, P = 0.48]. There were no further differences in subgroup analyses (continuous positive airway pressure-compliant patients, patients with severe obstructive sleep apnea or sleepy patients). However, after 24 weeks irrespective of initial randomization, vitamin D increased in patients with severe obstructive sleep apnea (9.56 ± 5.51 ng mL−1, P = 0.045) and in sleepy patients (14.0 ± 4.69 ng mL−1, P = 0.007). Also, there was a significant increase in osteocalcin at 24 weeks (3.27 ± 1.06 ng mL−1, P = 0.01) in compliant patients. We conclude that 12 weeks of continuous positive airway pressure did not modulate vitamin D or modulate any of the bone turnover markers compared with sham. However, it is plausible that continuous positive airway pressure may have late beneficial effects on vitamin D levels and bone turnover markers in selected groups of patients with obstructive sleep apnea.
AB - The aim was to investigate whether continuous positive airway pressure treatment could modulate serum vitamin D (25-hydroxyvitamin D) and bone turnover markers (collagen-type 1 cross-linked C-telopeptide, osteocalcin and N-terminal propeptide of type 1 collagen) in secondary analysis from a randomized controlled trial. Sixty-five continuous positive airway pressure-naïve male patients with obstructive sleep apnea (age = 49 ± 12 years, apnea–hypopnea index = 39.9 ± 17.7 events h−1, body mass index = 31.3 ± 5.2 kg m−2) were randomized to receive either real (n = 34) or sham (n = 31) continuous positive airway pressure for 12 weeks. At 12 weeks, all participants received real continuous positive airway pressure for an additional 12 weeks. After 12 weeks of continuous positive airway pressure (real versus sham), there were no between-group differences for any of the main outcomes [Δ25-hydroxyvitamin D: −0.80 ± 5.28 ng mL−1 (mean ± SE) versus 3.08 ± 3.66 ng mL−1, P = 0.42; Δcollagen-type 1 cross-linked C-telopeptide: 0.011 ± 0.014 ng mL−1 versus −0.004 ± 0.009 ng mL−1, P = 0.48; Δosteocalcin: 1.13 ± 1.12 ng mL−1 versus 0.46 ± 0.75 ng mL−1, P = 0.80; ΔN-terminal propeptide of type 1 collagen: 2.07 ± 3.05 μg L−1 versus −1.05 ± 2.13 μg L−1, P = 0.48]. There were no further differences in subgroup analyses (continuous positive airway pressure-compliant patients, patients with severe obstructive sleep apnea or sleepy patients). However, after 24 weeks irrespective of initial randomization, vitamin D increased in patients with severe obstructive sleep apnea (9.56 ± 5.51 ng mL−1, P = 0.045) and in sleepy patients (14.0 ± 4.69 ng mL−1, P = 0.007). Also, there was a significant increase in osteocalcin at 24 weeks (3.27 ± 1.06 ng mL−1, P = 0.01) in compliant patients. We conclude that 12 weeks of continuous positive airway pressure did not modulate vitamin D or modulate any of the bone turnover markers compared with sham. However, it is plausible that continuous positive airway pressure may have late beneficial effects on vitamin D levels and bone turnover markers in selected groups of patients with obstructive sleep apnea.
KW - bone turnover markers
KW - continuous positive airway pressure therapy
KW - obstructive sleep apnea
KW - randomized controlled trial
KW - vitamin D
UR - http://www.scopus.com/inward/record.url?scp=85030158751&partnerID=8YFLogxK
U2 - 10.1111/jsr.12606
DO - 10.1111/jsr.12606
M3 - Article
C2 - 28944524
AN - SCOPUS:85030158751
SN - 0962-1105
VL - 27
SP - 1
EP - 9
JO - Journal of Sleep Research
JF - Journal of Sleep Research
IS - 4
M1 - e12606
ER -